Related Experiment Video
Updated: Jun 28, 2026

09:19
Isolation of Human Umbilical Vein Endothelial Cells (HUVEC)
Published on: April 28, 2007
[Isolation and viability of human endothelial cells in tissue engineering]
Anales De La Real Academia Nacional De Medicina
|October 18, 2008
Summary
For tissue engineering, human umbilical vein endothelial cells (HUVECs) require optimal viability and function. The second cell passage of HUVECs offers the best balance for blood vessel construction protocols.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Vascular Biology
Background:
- Tissue engineering of human blood vessels relies on viable and functional endothelial cells (ECs).
- Primary cell cultures of human umbilical vein ECs are commonly used.
- Determining the optimal cell passage is crucial for successful tissue engineering.
Purpose of the Study:
- To identify the most appropriate cell passage of human umbilical vein ECs for tissue engineering protocols.
- To evaluate both cell viability and prostacyclin (PGI2) activity across different cell passages.
Main Methods:
- Cell viability assessed by quantifying intracellular ion concentrations using electron probe X-ray microanalysis.
- Prostacyclin (PGI2) release quantified via radioimmunoassay.
- Analysis of the K/Na ratio for cell passage-specific viability indicators.
Main Results:
- The K/Na ratio varied significantly between cell passages, indicating differential viability.
- Highest cell viability was observed in the third passage.
- PGI2 production was highest in the first two passages, declining significantly by the third passage.
Conclusions:
- The second cell passage of human umbilical vein ECs presents the optimal balance between cell viability and PGI2 functionality.
- This finding is critical for selecting the best cells for human blood vessel tissue engineering protocols.

